China News FeedArchive

China News Service · Health

中国新闻网 · Mainland official media · publisher's site

Analysis · What official media are saying from 70 stories · 8 h ago

China News Service spotlights APEC hosting, social welfare, and Chinese wins

Read the analysis

This set of China News Service official reporting prioritizes China's APEC host role, social welfare measures, and national achievements in sports and culture. International coverage focuses heavily on US technical and transport failures and Middle East conflict, while domestic items emphasize policy responsiveness and soft power. The selection is largely positive about China and omits contentious domestic or diplomatic frictions.

APEC hosting dominates coverage

Multiple items promote Shenzhen's APEC venues, the CEO summit, and qiaopi letters as evidence of Asia-Pacific people-to-people ties. A scholar is quoted dismissing Western talk of China's economic decline, and Xi Jinping cultural programs are set to air in APEC economies. This cluster frames the meeting as a showcase of Chinese openness and cultural continuity, while omitting any APEC agenda disputes or domestic constraints.

China News Service · WireChina News Service · WireChina News Service · WireChina News Service · WireChina News Service · Wire

Livelihood policies framed as responsive

Items on medical insurance mutual aid, elderly companionship, platform worker protections, and children's ticket rules present official and platform measures as addressing everyday needs. Some reports acknowledge complaints or legal disputes, such as insurer exemptions for riders, but the emphasis is on solutions and rollout. Absent are systemic cost, enforcement, or inequality problems behind these policies.

China News Service · SocietyChina News Service · Top storiesChina News Service · Top storiesChina News Service · SocietyChina News Service · Wire

US failures and global unrest reported

International items report a US Vulcan rocket failure, air travel grounding, and aging air traffic control, alongside Iran tanker mine incidents and Houthi-Saudi strikes. One item notes a US Starship test success, but the broader selection emphasizes instability abroad. No Chinese official response is included in these reports.

China News Service · WireChina News Service · WireChina News Service · WireChina News Service · WorldChina News Service · Top stories

Sports and culture project national pride

Reports celebrate Chinese victories in League of Legends, speed skating, women's football, and dragon boat, along with cultural events such as a Yellow River symposium and a Liu Jiakun architecture exhibition. These items present athletic and cultural achievements as signs of national vitality and confidence. The coverage does not mention commercial disputes, doping, or cultural restrictions.

China News Service · WireChina News Service · WireChina News Service · WireChina News Service · WireChina News Service · Wire

Regional development and ecology showcased

Items highlight Yunnan's RCEP education zone, Guangxi canal cultural tourism, Ningxia railway poverty reduction, and Urumqi metro expansion as local progress. Ecological stories include early fire prevention and migratory swans, framing environmental management as effective. The reports omit funding gaps, ethnic tensions, or environmental trade-offs.

China News Service · WireChina News Service · WireChina News Service · WireChina News Service · WireChina News Service · Wire

What to watch

  • Watch whether APEC coverage shifts from cultural and venue promotion to concrete summit outcomes or agreements.
  • Watch whether social welfare items follow up on the acknowledged disputes, such as rider insurance exemptions or children's ticket standards.
  • Watch whether international coverage adds Chinese official responses to the reported US failures and Middle East incidents.

Written by machine from the translated headlines and summaries of the linked stories; it can be wrong.

Jikeshu enters national medical insurance: one dose against influenza A and B, innovative drug benefits ordinary families

济可舒进医保:一剂对抗甲流乙流,创新药惠及普通家庭

The National Healthcare Security Administration published its 2026 national medical insurance drug catalogue on November 14, adding maxiloxavir tablets (Jikeshu), a domestic class-1 anti-influenza innovative drug developed by Jumpcan Pharmaceutical and Zhengxiang Pharma, to the list.

China News Service · Health 中国新闻网 · Society ·

Zhejiang University team first reveals lysosome calcium uptake mechanism, laying groundwork for rare disease research

浙大研究团队首次揭示溶酶体钙摄取机制 筑基罕见病研究

A Zhejiang University School of Medicine and Liangzhu Laboratory team led by Xu Haoxin published in Science, identifying proteins TMEM184B and TMEM184C as key to lysosomal calcium uptake and completing a puzzle that stood for more than 30 years.

China News Service · Health 中国新闻网 · Technology ·

National Health Commission: priority groups should be first to receive flu vaccine

国家卫健委:重点人群应优先接种流感疫苗

At a National Health Commission press conference, China CDC researcher Wang Dayan said annual flu vaccination is the most cost-effective prevention because the virus mutates easily, and priority groups, especially infants, people aged 60 and older, and chronic patients, should be vaccinated first.

China News Service · Health 中国新闻网 · Society ·

National Health Commission: when choosing prepackaged food, the key is the ingredient list and nutrition facts table

国家卫健委:预包装食品怎么选 关键看配料表和营养成分表

At a National Health Commission press conference, Liang Dong of the National Center for Food Safety Risk Assessment said consumers have different needs, but the ingredient list and nutrition facts table are the key when choosing prepackaged food.

China News Service · Health 中国新闻网 · Society ·

Stop enduring pain and taking medicine indiscriminately: key points on pain medication to remember

别再忍痛、乱吃药!关于疼痛用药这些要点千万记牢

At a National Health Commission press conference, Fan Bifa, chief physician at China-Japan Friendship Hospital, said claims that pain need not be treated or that aging inevitably brings pain are incorrect, and better daily health management can prevent chronic pain.

China News Service · Health 中国新闻网 · Society ·

NMPA approves marketing of Ruifuxibai monoclonal antibody injection (subcutaneous)

国家药监局批准芮弗西拜单抗注射液(皮下注射)上市

The National Medical Products Administration approved Beijing Shengdi Pharmaceutical's Ruifuxibai monoclonal antibody injection (subcutaneous), trade name Aiqingda, through priority review for adults and adolescents aged 12 and older with homozygous familial hypercholesterolemia, to lower LDL-C alongside a low-fat diet and other lipid-lowering drugs.

China News Service · Health 中国新闻网 · Society ·